Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sutcliffe

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Chemico-Biological Interactions|January 1, 1990
Hepatic microsomal warfarin metabolism in warfarin-resistant and susceptible mouse strains: influence of pretreatment with cytochrome P-450 inducersF A Sutcliffe, A D MacNicoll, G G Gibson
Antimicrobial Agents and Chemotherapy|January 1, 1990
In vitro assays used to measure the activity of topoisomerasesJ F Barrett, J A Sutcliffe, T D Gootz
Antimicrobial Agents and Chemotherapy|December 1, 1989
Biochemical characteristics and physiological significance of major DNA topoisomerasesJ A Sutcliffe, T D Gootz, J F Barrett
Reviews on Drug Metabolism and Drug Interactions|January 1, 1987
Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congenersF A Sutcliffe, A D MacNicoll, G G Gibson
Clinical and Vaccine Immunology : CVI|May 6, 2011
Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvantTarek Hamouda, Joyce A Sutcliffe, Susan Ciotti, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogensJ A Sutcliffe, W O'Brien, C Fyfe, et al.
International Journal of Antimicrobial Agents|July 15, 2017
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Joyce A Sutcliffe, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coliTrudy H Grossman, William O'Brien, Kathryn O Kerstein, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|November 2, 2006
Effect of attentional state on frequency discrimination: a comparison of children with ADHD on and off medicationPaul A Sutcliffe, Dorothy V M Bishop, Stephen Houghton, et al.
Journal of Medical Genetics|April 5, 2005
Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couplesM Ludwig, A Katalinic, S Gross, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Chemico-Biological Interactions|January 1, 1990
Hepatic microsomal warfarin metabolism in warfarin-resistant and susceptible mouse strains: influence of pretreatment with cytochrome P-450 inducersF A Sutcliffe, A D MacNicoll, G G Gibson
Antimicrobial Agents and Chemotherapy|January 1, 1990
In vitro assays used to measure the activity of topoisomerasesJ F Barrett, J A Sutcliffe, T D Gootz
Antimicrobial Agents and Chemotherapy|December 1, 1989
Biochemical characteristics and physiological significance of major DNA topoisomerasesJ A Sutcliffe, T D Gootz, J F Barrett
Reviews on Drug Metabolism and Drug Interactions|January 1, 1987
Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congenersF A Sutcliffe, A D MacNicoll, G G Gibson
Clinical and Vaccine Immunology : CVI|May 6, 2011
Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvantTarek Hamouda, Joyce A Sutcliffe, Susan Ciotti, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogensJ A Sutcliffe, W O'Brien, C Fyfe, et al.
International Journal of Antimicrobial Agents|July 15, 2017
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Joyce A Sutcliffe, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coliTrudy H Grossman, William O'Brien, Kathryn O Kerstein, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|November 2, 2006
Effect of attentional state on frequency discrimination: a comparison of children with ADHD on and off medicationPaul A Sutcliffe, Dorothy V M Bishop, Stephen Houghton, et al.
Journal of Medical Genetics|April 5, 2005
Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couplesM Ludwig, A Katalinic, S Gross, et al.
Pageof 10